News
Bioinformatics deciphers the metabolic characteristics of 25 types of cancer
Thanks to a bioinformatics analysis of 9,428 tumor samples, vulnerabilities potentially leading to new, more precise treatments are also identified
The 1st European Day GRIN2B brings together families suffering from this rare illness in Barcelona
Sant Joan de Déu Hospital hosts the event, through which parents will get to know the GRIN2B research team in Barcelona led by Dr. Xavier Altafaj, IDIBELL researcher
Dr. Manel Esteller, awarded by the ECO Foundation for Excellence and Quality of Oncology
Manel Esteller, director of the epigenetics and cancer biology program at IDIBELL, ICREA researcher and professor at the University of Barcelona, has received the Award of the ECO Foundation for Excellence and Quality in Oncology, awarded last Saturday 22nd at the Spanish Royal Academy of Medicine, in Madrid. The foundation has distinguished Dr. Esteller […]
ONCE and the Bellvitge Biomedical Research Institute (IDIBELL) renew their collaboration to study hereditary dystrophies of the retina
These dystrophies are disorders with great clinical and genetic heterogeneity for which there is no cure today; 15,000 people in Spain suffer from them
IDIBELL participates in the COST BESTPRAC meeting held in Belgrade, Serbia
The 10th BESTPRAC Working Group meeting was held from September 24-25 at the Faculty of Electrical Engineering, University of Belgrade, Serbia and gathered over 100 people from different European countries. IDIBELL attended the meeting as part of the action plan to boost its internationalization. COST BESTPRAC is one of the most relevant networks of research […]
IDIBELL researchers receive AECC grants on World Cancer Research Day
On the occasion of World Cancer Research Day (WCRD), which takes place every year on September 24th, the Spanish Association Against Cancer (AECC) awarded its 2018 AECC Cancer Research grants. The awards ceremony was chaired by Her Majesty the Queen, as Honorary President of the AECC and the AECC Scientific Foundation. This year, AECC has […]
Oncobell organises its first symposium
The 1st Oncobell symposium on “Mechanisms of cancer and new therapeutic strategies” officially introduces the IDIBELL cancer research program at a European level
Cycling for multiple sclerosis
From Reus to Puertollano – 665 kilometres – in 29 and a half hours. This is the result of an epic challenge fulfilled by José María Moya, a relative of a multiple sclerosis (MS) patient. This anonymous citizen decided to undertake a cycling challenge last September 7 and 8 to raise funds for the research […]
A new epigenetic signature predicts the response to immunotherapy in lung cancer
An article published in The Lancet Respiratory Medicine by Dr. Manel Esteller, Director of the Epigenetics and Cancer Biology Program (PEBC) of the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Researcher and Professor of Genetics at the University of Barcelona, proves that a specific pattern of epigenetic alterations in lung cancer predictss whether the tumor will […]